Exploring Extractables & Leachables studies for Orally Inhaled and Nasal Drug Products (OINDP) to ensure delivery system compliance

Nick Morley

By Engaged Expert

Nick Morley

More content from this author

Learn about our Engaged Experts

Principal Scientist for Life Sciences Manchester, Nick Morley has over 15 years of pharmaceutical laboratory experience predominantly specializing in extractables and leachables.

Dive into the world of extractable and leachable testing tailored for inhalation devices and orally inhaled nasal drug products (OINDP). In this webinar, hosted by Nick Morley, we help you overcome the challenges behind ensuring the safety and efficacy of these products.


Why should I watch this OINDP webinar?

In this webinar, we'll delve into the materials compliance challenges surrounding OINDPs, shedding light on the critical aspects that affect patient safety, and presenting you with the information required to safeguard patient health and maintain compliance with stringent regulatory standards. The webinar covers the following:

  • Ensuring patient safety: Learn how extractables and leachables testing ensures patient safety by identifying compounds that may migrate from materials used within OINDP and potentially harm end-users.
  • Navigating regulatory bodies: Understand the stringent regulatory requirements and guidelines set by bodies like the FDA and EMA to ensure OINDP safety and compliance.
  • Impacts of material choice: Explore real-life cases of OINDPs that reveal the impact of materials on product quality and patient outcomes, such as instances where leachables affected patient health.
  • Complexities in Testing: Gain insights into the unique challenges faced during testing, including the diverse range of chemical species and the evolving regulatory landscape pertinent to OINDP.


Standards Discussed

  • USP Standards: Explore USP <1663> and <1664>, providing guidance on assessment methods for extractables and leachables in pharmaceutical packaging systems.
  • ISO Guidelines: Understand the significance of ISO 10993 and ISO 18562, key standards governing biocompatibility and breathing gas pathway assessment for medical devices.
  • FDA Guidance: Delve into FDA guidelines for container closure systems, examining the critical regulatory aspects that shape extractable and leachable testing protocols.


Critical to OINDP safety

This webinar is of interest to Professionals involved in pharmaceuticals, medical devices, regulatory affairs, and quality control seeking a deeper understanding of extractable and leachable testing's impact on product safety and compliance.


Key topics covered in our webinar

  • Definitions and Differences: Understand the distinction between extractables and leachables and why their assessment is crucial for ensuring OINDP safety.
  • Risk Assessment: Explore the risk matrix highlighting the degrees of concern based on the root of administration and packaging component interaction likelihood.
  • Regulatory Insights: Gain valuable insights into how regulatory interests drive the need for meticulous extractable and leachable testing.
  • Challenges and Solutions in OINDP testing: Uncover the complexities of testing methodologies, reporting thresholds, and detection limits, and explore potential solutions.


Watch our OINDP Webinar

Don't miss this opportunity to explore the pivotal role of extractable and leachable testing in ensuring the safety and efficacy of inhaler and nasal drug products. Download now and gain invaluable insights from industry expert Nick Morley.

For inquiries or further information, contact us directly. We're here to address your concerns and guide you through this critical aspect of product development.


Exploring Extractables & Leachables studies for Orally Inhaled and Nasal Drug Products (OINDP) to ensure packaging and delivery system compliance - excerpt.

"Extractables are compounds that can be extracted from a device container closure system or processing equipment under exaggerated conditions... Leachables, on the other hand, are compounds that migrate during the manufacturer storage or clinical use conditions... Extractable data gives us an idea of the potential impact, whereas leachable data gives us an idea of the actual impact of the materials that are used."


To watch this webinar, complete the form below

Find related Resources

About the author

As principal Scientist for Life Sciences Manchester, Nick Morley has over 15 years of pharmaceutical laboratory experience predominantly specializing in extractables and leachables.

As a trusted authority within the Life Science industry, Nick provides clients with technical guidance for design studies, authors whitepapers, presents at conferences and collaborates with external scientific organisations to keep up to date with the latest trends.

Nick is passionate about helping our clients deliver innovative products that enable patients to live healthier and more comfortable lives.

Nick Morley
Nick Morley
Life Sciences_Content

Life Sciences Content

Check out our Life Sciences thought leadership content including webinars, white papers, case studies blogs and more.

Written by our industry experts, we tackle a range of subjects across Antimicrobial, Biotechnology Food, Medical Device, Pharmaceutical, and Personal Care industries.

With a commitment to absolute certainty, we utilize our extensive expertise and experience to provide insights that ensure the safety of materials used in the life science sector.


Related Pages

Pharmaceutical Testing Extractables and Leachables

Extractables and Leachables Studies

Element's extractables and leachables studies offer tailored solutions that ensure patient safety and compliance with industry standards.

Read More

Medical Device Testing

As a comprehensive testing partner, you’ll enjoy the benefit of a single supplier source for all of your testing needs, from mechanical testing and environmental simulation to EMC and wireless device testing.

Read More
pharmaceutical testing

Pharmaceutical Testing

Element’s pharmaceutical laboratories provide specialist pharmaceutical testing services, including chemical, physical, microbial, and stability testing on a vast array of products, from raw materials to finished products.

Read More
IS0 18562-2

ISO 18562 Testing: Biocompatibility Analysis

Element provides ISO 18562 biocompatibility analysis for respiratory and ventilation devices to support global device approval.

USP 665 Testing

USP 665, 1665 and BPOG Services

Ensure compliance for single-use systems (SUS). Our testing services provide high-quality results, safeguarding patient safety, fulfilling your regulatory requirements, and expediting time to market.

Pharmaceutical raw materials testing

Excipient Raw Materials and Container Testing

Find out how we make certain that quality and safety of your excipient raw materials and containers are maintained.

Connect with Element Life Sciences.

Chemistry, Manufacturing, and Controls (CMC) Consulting Services

We provide consulting services for Chemistry, Manufacturing, and Controls (CMC) product development in the pharmaceutical and biotechnological industries.

Connect with Element Life Sciences

ICH Stability Testing of Pharmaceuticals and Biologics

We'll help you develop comprehensive stability programs that meet ICH Q1A-F requirements for IND, ANDA, and NDA approvals of small and large molecule drugs. 

Read more

Our team of over 9,000 Engaged Experts in North America, Europe, The Middle East, Australia, Asia and Africa are ready to help you.